Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	DHX16 ATP5PB MYH3 MYO1E CFTR AK6 CHD8 SMC5 ATAD2B RECQL4 HFM1 CHD6	1.06e-04	441	147	12	GO:0016887
GeneOntologyMolecularFunction	ubiquitin conjugating enzyme activity	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	1.54e-04	37	147	4	GO:0061631
GeneOntologyMolecularFunction	ubiquitin-like protein conjugating enzyme activity	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	2.78e-04	43	147	4	GO:0061650
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ARHGAP24 DOCK11 RAPGEF5 TBC1D2B PREX2 RCC1L ASAP2 RALGPS1 RASGEF1B RIMS1 ALDH1A1 ACAP2	3.80e-04	507	147	12	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ARHGAP24 DOCK11 RAPGEF5 TBC1D2B PREX2 RCC1L ASAP2 RALGPS1 RASGEF1B RIMS1 ALDH1A1 ACAP2	3.80e-04	507	147	12	GO:0030695
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor activity	HTR1F CHRM5 HRH2	5.43e-04	22	147	3	GO:0004993
GeneOntologyMolecularFunction	nucleoside monophosphate kinase activity	AK6 AK5 DLG1	6.21e-04	23	147	3	GO:0050145
GeneOntologyMolecularFunction	ATP-dependent activity	DHX16 ATP5PB MYH3 MYO1E CFTR AK6 CHD8 ZNFX1 SMC5 ATAD2B RECQL4 HFM1 CHD6	6.24e-04	614	147	13	GO:0140657
GeneOntologyBiologicalProcess	digestive tract development	TIGAR CDX2 TCF7L2 CHD8 CCDC39 HOXA5 NPHP3 HRH2	1.36e-05	152	147	8	GO:0048565
GeneOntologyBiologicalProcess	epithelium development	KRT72 KRAS TIGAR DLG5 CDX1 CDX2 TCF7L2 ARHGAP24 MYO1E KRT74 CFTR SHANK3 CCDC39 HOXA5 NCOR2 GRHL1 NPHP3 PBRM1 ALMS1 KRT71 BRCA2 PCDH15 HRH2 DLG1 ALDH1A1 ALDH1A3	1.41e-05	1469	147	26	GO:0060429
GeneOntologyBiologicalProcess	digestive system development	TIGAR CDX2 TCF7L2 CHD8 CCDC39 HOXA5 NPHP3 HRH2	2.68e-05	167	147	8	GO:0055123
GeneOntologyBiologicalProcess	animal organ morphogenesis	KRAS DLG5 CDX1 CDX2 TCF7L2 CDX4 CFTR NAB2 SHANK3 CCDC39 CASZ1 ITPR1 HOXA5 NCOR2 NPHP3 SULF2 PBRM1 ALMS1 RECQL4 PCDH15 DLG1 ALDH1A1 ALDH1A3	3.28e-05	1269	147	23	GO:0009887
GeneOntologyBiologicalProcess	embryo development	GDF5 MYH3 CDX1 CDX2 TCF7L2 CDX4 MYO1E CAPN2 LMBR1 CHD8 NIBAN2 PAF1 SHANK3 CCDC39 HOXA5 NCOR2 NPHP3 SULF2 PBRM1 BRCA2 PCDH15 DLG1 ALDH1A1 ALDH1A3	7.93e-05	1437	147	24	GO:0009790
GeneOntologyBiologicalProcess	protein K29-linked ubiquitination	UBE2D2 UBE2D3 UBE2D4	9.63e-05	13	147	3	GO:0035519
Domain	Caudal_act	CDX1 CDX2 CDX4	4.98e-07	3	149	3	PF04731
Domain	Caudal_activation_dom	CDX1 CDX2 CDX4	4.98e-07	3	149	3	IPR006820
Domain	P-loop_NTPase	DHX16 KRAS MYH3 DLG5 MYO1E CFTR AK6 CHD8 ZNFX1 SMC5 NPHP3 AK5 ATAD2B RECQL4 ASPM DLG1 HFM1 CHD6	1.46e-04	848	149	18	IPR027417
Domain	DNA/RNA_helicase_DEAH_CS	DHX16 CHD8 RECQL4 CHD6	1.68e-04	35	149	4	IPR002464
Domain	FerA	DYSF MYOF	1.89e-04	3	149	2	SM01200
Domain	Ferlin_A-domain	DYSF MYOF	1.89e-04	3	149	2	IPR012560
Domain	FerA	DYSF MYOF	1.89e-04	3	149	2	PF08165
Domain	DEAH_ATP_HELICASE	DHX16 CHD8 RECQL4 CHD6	2.33e-04	38	149	4	PS00690
Domain	UQ_con	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	2.58e-04	39	149	4	PF00179
Domain	UBIQUITIN_CONJUGAT_1	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	2.84e-04	40	149	4	PS00183
Domain	-	DHX16 KRAS DLG5 MYO1E CFTR AK6 CHD8 ZNFX1 SMC5 NPHP3 AK5 ATAD2B RECQL4 DLG1 HFM1 CHD6	3.11e-04	746	149	16	3.40.50.300
Domain	UBIQUITIN_CONJUGAT_2	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	3.13e-04	41	149	4	PS50127
Domain	UBQ-conjugat_E2	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	3.13e-04	41	149	4	IPR000608
Domain	DysFC	DYSF MYOF	3.75e-04	4	149	2	SM00694
Domain	DysFN	DYSF MYOF	3.75e-04	4	149	2	SM00693
Domain	Peroxin/Ferlin	DYSF MYOF	3.75e-04	4	149	2	IPR006614
Domain	FerI	DYSF MYOF	6.22e-04	5	149	2	SM01202
Domain	FerB	DYSF MYOF	6.22e-04	5	149	2	SM01201
Domain	Ferlin_B-domain	DYSF MYOF	6.22e-04	5	149	2	IPR012561
Domain	Ferlin_C	DYSF MYOF	6.22e-04	5	149	2	PF16165
Domain	Ferlin_C	DYSF MYOF	6.22e-04	5	149	2	IPR032362
Domain	FerIin_dom	DYSF MYOF	6.22e-04	5	149	2	IPR012968
Domain	FerI	DYSF MYOF	6.22e-04	5	149	2	PF08151
Domain	FerB	DYSF MYOF	6.22e-04	5	149	2	PF08150
Domain	-	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	7.27e-04	51	149	4	3.10.110.10
Domain	UBQ-conjugating_enzyme/RWD	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	8.41e-04	53	149	4	IPR016135
Domain	Keratin_2_head	KRT72 KRT74 KRT71	8.91e-04	24	149	3	IPR032444
Domain	Keratin_2_head	KRT72 KRT74 KRT71	8.91e-04	24	149	3	PF16208
Domain	BRK	CHD8 CHD6	9.29e-04	6	149	2	SM00592
Domain	BRK_domain	CHD8 CHD6	9.29e-04	6	149	2	IPR006576
Domain	BRK	CHD8 CHD6	9.29e-04	6	149	2	PF07533
Domain	UBQ-conjugating_AS	UBE2D2 UBE2D3 UBE2D4	1.01e-03	25	149	3	IPR023313
Domain	RASGEF	RAPGEF5 RALGPS1 RASGEF1B	1.13e-03	26	149	3	PS00720
Domain	Keratin_II	KRT72 KRT74 KRT71	1.13e-03	26	149	3	IPR003054
Domain	RASGEF_CAT	RAPGEF5 RALGPS1 RASGEF1B	1.56e-03	29	149	3	PS50009
Domain	Helicase_C	DHX16 CHD8 RECQL4 HFM1 CHD6	1.67e-03	107	149	5	PF00271
Domain	HELICc	DHX16 CHD8 RECQL4 HFM1 CHD6	1.67e-03	107	149	5	SM00490
Domain	RasGEF	RAPGEF5 RALGPS1 RASGEF1B	1.73e-03	30	149	3	PF00617
Domain	-	RAPGEF5 RALGPS1 RASGEF1B	1.73e-03	30	149	3	1.10.840.10
Domain	RASGEF_cat_dom	RAPGEF5 RALGPS1 RASGEF1B	1.73e-03	30	149	3	IPR001895
Domain	RasGEF	RAPGEF5 RALGPS1 RASGEF1B	1.73e-03	30	149	3	SM00147
Domain	Ras_GEF_dom	RAPGEF5 RALGPS1 RASGEF1B	1.73e-03	30	149	3	IPR023578
Domain	Helicase_C	DHX16 CHD8 RECQL4 HFM1 CHD6	1.74e-03	108	149	5	IPR001650
Domain	SH3	DLG5 NEBL MYO1E SHANK3 ASAP2 ZDHHC6 DLG1	1.76e-03	216	149	7	SM00326
Domain	PH	ARHGAP24 DOCK11 TBC1D2B NIBAN2 PREX2 ASAP2 RALGPS1 ACAP2	1.78e-03	278	149	8	SM00233
Domain	HELICASE_CTER	DHX16 CHD8 RECQL4 HFM1 CHD6	1.81e-03	109	149	5	PS51194
Domain	HELICASE_ATP_BIND_1	DHX16 CHD8 RECQL4 HFM1 CHD6	1.81e-03	109	149	5	PS51192
Domain	DEXDc	DHX16 CHD8 RECQL4 HFM1 CHD6	1.81e-03	109	149	5	SM00487
Domain	PH_DOMAIN	ARHGAP24 DOCK11 TBC1D2B NIBAN2 PREX2 ASAP2 RALGPS1 ACAP2	1.82e-03	279	149	8	PS50003
Domain	PH_domain	ARHGAP24 DOCK11 TBC1D2B NIBAN2 PREX2 ASAP2 RALGPS1 ACAP2	1.86e-03	280	149	8	IPR001849
Domain	Helicase_ATP-bd	DHX16 CHD8 RECQL4 HFM1 CHD6	1.89e-03	110	149	5	IPR014001
Domain	SH3_domain	DLG5 NEBL MYO1E SHANK3 ASAP2 ZDHHC6 DLG1	1.95e-03	220	149	7	IPR001452
Domain	PH	ARHGAP24 DOCK11 TBC1D2B PREX2 ASAP2 RALGPS1 ACAP2	2.45e-03	229	149	7	PF00169
Domain	Filament	KRT72 IFFO1 KRT74 KRT71	2.50e-03	71	149	4	SM01391
Domain	BROMODOMAIN_1	BRWD3 PBRM1 ATAD2B	3.17e-03	37	149	3	PS00633
Domain	IF	KRT72 IFFO1 KRT74 KRT71	3.20e-03	76	149	4	IPR001664
Domain	Bromodomain	BRWD3 PBRM1 ATAD2B	3.42e-03	38	149	3	PF00439
Domain	BROMODOMAIN_2	BRWD3 PBRM1 ATAD2B	4.25e-03	41	149	3	PS50014
Domain	Bromodomain	BRWD3 PBRM1 ATAD2B	4.55e-03	42	149	3	IPR001487
Domain	BROMO	BRWD3 PBRM1 ATAD2B	4.55e-03	42	149	3	SM00297
Domain	-	BRWD3 PBRM1 ATAD2B	4.55e-03	42	149	3	1.20.920.10
Domain	Ras_G-nucl-exch_fac_CS	RAPGEF5 RASGEF1B	5.40e-03	14	149	2	IPR019804
Domain	PDZ	DLG5 SHANK3 PREX2 DLG1 RIMS1	5.48e-03	141	149	5	PF00595
Domain	Homeobox_metazoa	CDX1 CDX2 CDX4 HOXA5	5.85e-03	90	149	4	IPR020479
Domain	PDZ	DLG5 SHANK3 PREX2 DLG1 RIMS1	6.71e-03	148	149	5	SM00228
Domain	Ald_DH_CS_GLU	ALDH1A1 ALDH1A3	7.05e-03	16	149	2	IPR029510
Domain	-	DLG5 SHANK3 PREX2 DLG1 RIMS1	7.09e-03	150	149	5	2.30.42.10
Domain	PDZ	DLG5 SHANK3 PREX2 DLG1 RIMS1	7.29e-03	151	149	5	PS50106
Domain	PDZ	DLG5 SHANK3 PREX2 DLG1 RIMS1	7.49e-03	152	149	5	IPR001478
Domain	Ank_2	SHANK3 ANKRD36B ASAP2 ANKRD36 ACAP2 SOWAHB	7.64e-03	215	149	6	PF12796
Domain	SH3	DLG5 NEBL MYO1E SHANK3 ASAP2 DLG1	7.80e-03	216	149	6	PS50002
Domain	Ald_DH_CS_CYS	ALDH1A1 ALDH1A3	7.95e-03	17	149	2	IPR016160
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ATP5PB KRT72 MYH3 KRT74 TM9SF3 COQ6 UTP14A KRBA2 DNAJC7 OGDH CYB5B SNRNP48 KRT71 PIP4K2A UNC5C ASPM TENM1 DLG1 CHD6 EIF3A RIMS1 ALDH1A1 TMCO1	6.37e-08	1442	150	23	35575683
Pubmed	Cdx4 is a Cdx2 target gene.	CDX1 CDX2 CDX4	7.86e-08	3	150	3	20933081
Pubmed	Cdx gene deficiency compromises embryonic hematopoiesis in the mouse.	CDX1 CDX2 CDX4	7.86e-08	3	150	3	18511567
Pubmed	[Expression and clinical significance of caudal type homeobox transcription factor-2 in adult acute lymphocytic leukemia].	CDX1 CDX2 CDX4	7.86e-08	3	150	3	21518475
Pubmed	Anterior expression of the caudal homologue cCdx-B activates a posterior genetic program in avian embryos.	CDX1 CDX2 CDX4	7.86e-08	3	150	3	11500978
Pubmed	Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes.	CDX1 CDX2 CDX4	7.86e-08	3	150	3	18252864
Pubmed	cdx4/lacZ and cdx2/lacZ protein gradients formed by decay during gastrulation in the mouse.	CDX1 CDX2 CDX4	7.86e-08	3	150	3	16281167
Pubmed	K6irs1, K6irs2, K6irs3, and K6irs4 represent the inner-root-sheath-specific type II epithelial keratins of the human hair follicle.	KRT72 KRT74 KRT71	3.14e-07	4	150	3	12648212
Pubmed	Increased Cdx protein dose effects upon axial patterning in transgenic lines of mice.	CDX1 CDX2 CDX4	3.14e-07	4	150	3	18579683
Pubmed	Nervous System Regionalization Entails Axial Allocation before Neural Differentiation.	CDX1 CDX2 CDX4	3.14e-07	4	150	3	30343898
Pubmed	Cdx1 and Cdx2 are functionally equivalent in vertebral patterning.	CDX1 CDX2 CDX4	7.81e-07	5	150	3	19328777
Pubmed	Synthesis of Isomeric Phosphoubiquitin Chains Reveals that Phosphorylation Controls Deubiquitinase Activity and Specificity.	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	1.23e-06	19	150	4	27425610
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	DLG5 TTLL5 UTP14A TBC1D2B NCOR2 ALMS1 SVIL PIBF1	1.46e-06	184	150	8	32908313
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIAA0930 UTP14A ZFP28 SHANK3 CASZ1 MYOF ASAP2 NPHP3 ALMS1 CNTNAP4 EIF3A SSH2	1.70e-06	493	150	12	15368895
Pubmed	Evolutionarily conserved requirement of Cdx for post-occipital tissue emergence.	CDX1 CDX2 CDX4 HOXA5	1.88e-06	21	150	4	22675207
Pubmed	The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.	UBE2D2 UBE2D3 UBE2D4	2.72e-06	7	150	3	21685362
Pubmed	Developmental regulation of the Hox genes during axial morphogenesis in the mouse.	CDX1 CDX2 CDX4	2.72e-06	7	150	3	15944185
Pubmed	Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.	UBE2D2 UBE2D3 UBE2D4	2.72e-06	7	150	3	30884854
Pubmed	Cdx is crucial for the timing mechanism driving colinear Hox activation and defines a trunk segment in the Hox cluster topology.	CDX1 CDX2 CDX4 HOXA5	2.76e-06	23	150	4	28041967
Pubmed	The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway.	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	2.76e-06	23	150	4	30017913
Pubmed	Ube2W conjugates ubiquitin to α-amino groups of protein N-termini.	UBE2D2 UBE2D3 UBE2D4	4.33e-06	8	150	3	23560854
Pubmed	Role of Cdx factors in early mesodermal fate decisions.	CDX1 CDX2 CDX4	4.33e-06	8	150	3	30936115
Pubmed	Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase.	UBE2D2 UBE2D3 UBE2D4	4.33e-06	8	150	3	28681414
Pubmed	Inhibition of UVSSA ubiquitination suppresses transcription-coupled nucleotide excision repair deficiency caused by dissociation from USP7.	UBE2D2 UBE2D3 UBE2D4	4.33e-06	8	150	3	29323787
Pubmed	The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines.	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	4.62e-06	26	150	4	20061386
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	ATP5PB SNX3 NAB2 TM9SF3 FASTKD1 PPIL4 CHD8 OGDH ITPR1 GGH CYB5B CRNKL1 NCOR2 KARS1 TXNDC5 PIP4K2A UNC5C EMD TMCO1 RPL5	4.64e-06	1451	150	20	30550785
Pubmed	Real-time tracking of complex ubiquitination cascades using a fluorescent confocal on-bead assay.	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	5.40e-06	27	150	4	30097011
Pubmed	Pdx1-related homeodomain transcription factors are distinctly expressed in mouse adult pancreatic islets.	CDX1 CDX2 CDX4	6.48e-06	9	150	3	15888377
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	TDRD15 CCDC168 NCOR2 UBE2D3 ZER1 ACAP2 SOWAHB	8.92e-06	168	150	7	30631154
Pubmed	Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib.	UBE2D2 UBE2D3 UBE2Q2	9.23e-06	10	150	3	33607208
Pubmed	Mechanism and chain specificity of RNF216/TRIAD3, the ubiquitin ligase mutated in Gordon Holmes syndrome.	UBE2D2 UBE2D3 UBE2D4	9.23e-06	10	150	3	31087003
Pubmed	Osmotic and heat stress-dependent regulation of MLK4β and MLK3 by the CHIP E3 ligase in ovarian cancer cells.	UBE2D2 UBE2D3 UBE2D4	9.23e-06	10	150	3	28757353
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SNX17 MPZL1 NIBAN2 PAF1 DNAJC7 ITPR1 NCOR2 KARS1 TXNDC5 MTUS1 SVIL DLG1 SSH2 EMD PIBF1 PLK1	1.31e-05	1049	150	16	27880917
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	DLG5 TCF7L2 NEBL TM9SF3 ZNF248 MYOF SVIL PIP4K2A PCDH15 EIF3A	1.39e-05	415	150	10	16385451
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	DHX16 SNX3 TM9SF3 UTP14A AK6 CHD8 PAF1 CRNKL1 RCC1L KARS1 PBRM1 UBE2D3 PIP4K2A CHD6 EIF3A EMD PLK1 RPL5	1.63e-05	1318	150	18	30463901
Pubmed	The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes.	UBE2D2 UBE2D3 UBE2D4	1.68e-05	12	150	3	24211586
Pubmed	Wnt-3a is required for somite specification along the anteroposterior axis of the mouse embryo and for regulation of cdx-1 expression.	CDX1 CDX2 CDX4	1.68e-05	12	150	3	11335109
Pubmed	Differential regulation of CDX1 and CDX2 gene expression by deficiency in methyl group donors.	CDX1 CDX2	1.85e-05	2	150	2	18187048
Pubmed	Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes.	ASPM PLK1	1.85e-05	2	150	2	11283617
Pubmed	Inositol 1,4,5-trisphosphate receptor 1, a widespread Ca2+ channel, is a novel substrate of polo-like kinase 1 in eggs.	ITPR1 PLK1	1.85e-05	2	150	2	18621368
Pubmed	Differential gene expression in normal esophagus and Barrett's esophagus.	CDX1 CDX2	1.85e-05	2	150	2	19468668
Pubmed	HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.	TXNDC5 KCNH2	1.85e-05	2	150	2	31331361
Pubmed	Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression.	BRCA2 PLK1	1.85e-05	2	150	2	14647413
Pubmed	Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.	ALDH1A1 ALDH1A3	1.85e-05	2	150	2	34428540
Pubmed	Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol.	KCNV2 KCNH2	1.85e-05	2	150	2	18708743
Pubmed	CHD6 regulates the topological arrangement of the CFTR locus.	CFTR CHD6	1.85e-05	2	150	2	25631877
Pubmed	Aberrant accumulation of Kras-dependent pervasive transcripts during tumor progression renders cancer cells dependent on PAF1 expression.	KRAS PAF1	1.85e-05	2	150	2	37572321
Pubmed	Nonsyndromic Early-Onset Cone-Rod Dystrophy and Limb-Girdle Muscular Dystrophy in a Consanguineous Israeli Family are Caused by Two Independent yet Linked Mutations in ALMS1 and DYSF.	DYSF ALMS1	1.85e-05	2	150	2	26077327
Pubmed	Cdx function is required for maintenance of intestinal identity in the adult.	CDX1 CDX2	1.85e-05	2	150	2	22285812
Pubmed	Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b.	DYSF MYOF	1.85e-05	2	150	2	18495154
Pubmed	Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus.	CDX1 CDX2	1.85e-05	2	150	2	23918153
Pubmed	Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.	PBRM1 ALDH1A1	1.85e-05	2	150	2	35412614
Pubmed	The Transcription Factor 7-Like 2-Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Axis Connects Mitochondrial Biogenesis and Metabolic Shift with Stem Cell Commitment to Hepatic Differentiation.	TCF7L2 PPARGC1A	1.85e-05	2	150	2	28795454
Pubmed	Cdx1 and Cdx2 exhibit transcriptional specificity in the intestine.	CDX1 CDX2	1.85e-05	2	150	2	23382958
Pubmed	Cdx binding determines the timing of enhancer activation in postnatal duodenum.	CDX1 CDX2	1.85e-05	2	150	2	15677472
Pubmed	Follow-Up Study on CDX1 and CDX2 mRNA Expression in Noncancerous Gastric Mucosae After Helicobacter pylori Eradication.	CDX1 CDX2	1.85e-05	2	150	2	26841784
Pubmed	[Identity and intestinal pathologies: the Cdx2 homeotic gene].	CDX1 CDX2	1.85e-05	2	150	2	23127929
Pubmed	The homeodomain transcription factors Cdx1 and Cdx2 induce E-cadherin adhesion activity by reducing beta- and p120-catenin tyrosine phosphorylation.	CDX1 CDX2	1.85e-05	2	150	2	17463179
Pubmed	Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains.	DYSF MYOF	1.85e-05	2	150	2	11959863
Pubmed	Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity.	UBE2D2 UBE2D4	1.85e-05	2	150	2	26912277
Pubmed	Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle.	DYSF MYOF	1.85e-05	2	150	2	34354129
Pubmed	Aldehyde dehydrogenase 6, a cytosolic retinaldehyde dehydrogenase prominently expressed in sensory neuroepithelia during development.	ALDH1A1 ALDH1A3	1.85e-05	2	150	2	11013254
Pubmed	TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions.	CDX2 TCF7L2	1.85e-05	2	150	2	20696899
Pubmed	The caudal-related homeodomain protein Cdx-2/3 regulates glucagon gene expression in islet cells.	CDX2 CDX4	1.85e-05	2	150	2	8910549
Pubmed	Interactions between Cdx genes and retinoic acid modulate early cardiogenesis.	CDX1 CDX4	1.85e-05	2	150	2	21466798
Pubmed	Cdx mutant axial progenitor cells are rescued by grafting to a wild type environment.	CDX2 CDX4	1.85e-05	2	150	2	20816799
Pubmed	Cdx1 and cdx2 expression during intestinal development.	CDX1 CDX2	1.85e-05	2	150	2	11040183
Pubmed	Keratin K6irs is specific to the inner root sheath of hair follicles in mice and humans.	KRT72 KRT71	1.85e-05	2	150	2	11703281
Pubmed	The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing.	SVIL PLK1	1.85e-05	2	150	2	23750008
Pubmed	Aldehyde dehydrogenase activity is a biomarker of primitive normal human mammary luminal cells.	ALDH1A1 ALDH1A3	1.85e-05	2	150	2	22131125
Pubmed	Regulation of axial elongation by Cdx.	CDX1 CDX2	1.85e-05	2	150	2	34958748
Pubmed	The Cdx-1 and Cdx-2 homeobox genes in the intestine.	CDX1 CDX2	1.85e-05	2	150	2	10392709
Pubmed	Expression of DLG1 and DLG5 in the Intestinal Epithelium of Patients with CD.	DLG5 DLG1	1.85e-05	2	150	2	27760079
Pubmed	Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.	KRAS PLK1	1.85e-05	2	150	2	23566315
Pubmed	Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.	CFTR EIF3A	1.85e-05	2	150	2	30006345
Pubmed	Identification of RALDH-3, a novel retinaldehyde dehydrogenase, expressed in the ventral region of the retina.	ALDH1A1 ALDH1A3	1.85e-05	2	150	2	11044606
Pubmed	Structural Basis for the Distinct Membrane Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin.	DYSF MYOF	1.85e-05	2	150	2	31004665
Pubmed	Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis.	CDX1 CDX2	1.85e-05	2	150	2	9036867
Pubmed	Cdx regulates gene expression through PRC2-mediated epigenetic mechanisms.	CDX1 CDX2	1.85e-05	2	150	2	34973175
Pubmed	While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems.	DYSF MYOF	1.85e-05	2	150	2	19228595
Pubmed	CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer.	CDX1 CDX2	1.85e-05	2	150	2	21532856
Pubmed	Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia.	KRAS CEMIP	1.85e-05	2	150	2	27922049
Pubmed	[Impact of Cystic Fibrosis Transmembrane Conductance Regulator on Malignant  Properties of KRAS Mutant Lung Adenocarcinoma A549 Cells].	KRAS CFTR	1.85e-05	2	150	2	29526175
Pubmed	ALDH1A1 and ALDH1A3 paralogues of aldehyde dehydrogenase 1 control myogenic differentiation of skeletal muscle satellite cells by retinoic acid-dependent and -independent mechanisms.	ALDH1A1 ALDH1A3	1.85e-05	2	150	2	37904003
Pubmed	Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation.	CDX1 CDX2	1.85e-05	2	150	2	17595234
Pubmed	Essential and redundant functions of caudal family proteins in activating adult intestinal genes.	CDX1 CDX2	1.85e-05	2	150	2	21402776
Pubmed	Transgenic Cdx2 induces endogenous Cdx1 in intestinal metaplasia of Cdx2-transgenic mouse stomach.	CDX1 CDX2	1.85e-05	2	150	2	19725873
Pubmed	Ubiquitination of STING at lysine 224 controls IRF3 activation.	UBE2D2 UBE2D3 UBE2D4	2.18e-05	13	150	3	28763789
Pubmed	NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.	NIBAN2 BRCA2 CHD6	2.18e-05	13	150	3	28416489
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	DHX16 ZNFX1 CEMIP ASAP2 ALMS1 CNTNAP4	2.24e-05	130	150	6	12421765
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TM9SF3 ZNFX1 ZDBF2 CASZ1 ANKRD36B CYB5B NCOR2 PBRM1 TXNDC5 UNC5C HFM1 CHD6	2.27e-05	638	150	12	31182584
Pubmed	Effect of retinoic acid signaling on Wnt/beta-catenin and FGF signaling during body axis extension.	CDX1 CDX2 CDX4	2.76e-05	14	150	3	19539783
Pubmed	Essential roles for Cdx in murine primitive hematopoiesis.	CDX1 CDX2 CDX4	2.76e-05	14	150	3	28065741
Pubmed	Divergent self-association properties of paralogous proteins TRIM2 and TRIM3 regulate their E3 ligase activity.	UBE2D2 UBE2D3 UBE2D4	2.76e-05	14	150	3	36481767
Pubmed	Cdx2 is essential for axial elongation in mouse development.	CDX1 CDX2 CDX4	3.44e-05	15	150	3	15136723
Pubmed	The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.	GDF5 TCF7L2 GDAP1 RECQL4 DLG1 PLK1	3.98e-05	144	150	6	30585266
Pubmed	Hindgut defects and transformation of the gastro-intestinal tract in Tcf4(-/-)/Tcf1(-/-) embryos.	CDX1 CDX2 TCF7L2	4.23e-05	16	150	3	15057272
Pubmed	Cdx2 regulation of posterior development through non-Hox targets.	CDX1 CDX2 CDX4	4.23e-05	16	150	3	19906845
Pubmed	Concerted involvement of Cdx/Hox genes and Wnt signaling in morphogenesis of the caudal neural tube and cloacal derivatives from the posterior growth zone.	CDX2 CDX4 ALDH1A3	4.23e-05	16	150	3	21752936
Pubmed	Functional interaction of ubiquitin ligase RNF167 with UBE2D1 and UBE2N promotes ubiquitination of AMPA receptor.	UBE2D2 UBE2D3 UBE2D4	5.12e-05	17	150	3	33650289
Interaction	UVSSA interactions	UBE2D2 UBE2D3 UBE2D4 RECQL4 EMD	7.69e-06	37	150	5	int:UVSSA
Interaction	TRIM35 interactions	TIGAR TCF7L2 OTUD5 NAB2 UBE2D2 UBE2D3 UBE2D4	1.20e-05	103	150	7	int:TRIM35
Interaction	MIB1 interactions	ARHGAP24 TTLL5 CEMIP CRNKL1 UBE2D2 UBE2D3 UBE2D4 EIF3A EMD PIBF1 PLK1	1.35e-05	295	150	11	int:MIB1
Interaction	CSNK2B interactions	KRAS TCF7L2 MLX UTP14A CHD8 PAF1 SMC5 SHANK3 ATAD2B PIP4K2A RECQL4 TENM1 TNFAIP1 EMD PLK1 RPL5	1.77e-05	625	150	16	int:CSNK2B
Interaction	TRIM37 interactions	DLG5 MYO1E KRT74 TTLL5 UTP14A TBC1D2B CYB5B NCOR2 MYOF UBE2D2 UBE2D3 ALMS1 SVIL EMD PIBF1 RPL5	1.95e-05	630	150	16	int:TRIM37
Interaction	DKK3 interactions	ATP5PB IFFO1 SULF2 ALMS1 RECQL4 ASPM	2.03e-05	75	150	6	int:DKK3
Interaction	LZTS2 interactions	DHX16 KRAS DLG5 NEBL TBC1D2B SHANK3 CRNKL1 ALMS1 BRCA2 PIP4K2A RECQL4 ASPM GCC1 EMD	2.98e-05	512	150	14	int:LZTS2
Interaction	UTP14C interactions	NAB2 UTP14A BRCA2 GCC1 PIBF1	3.46e-05	50	150	5	int:UTP14C
Interaction	POLM interactions	KRAS UBE2D2 UBE2D3 MTUS1	3.88e-05	26	150	4	int:POLM
Interaction	HSPB8 interactions	MYH3 TCF7L2 NAB2 TBC1D2B ALMS1 BRCA2 ZER1 EMD	4.50e-05	172	150	8	int:HSPB8
Interaction	KRT38 interactions	KRT72 KRT74 TXNDC5 ALMS1 KRT71 BRCA2 ASPM PIBF1	4.50e-05	172	150	8	int:KRT38
Interaction	MYLIP interactions	KRAS PAF1 UBE2D2 UBE2D3 UBE2D4	6.01e-05	56	150	5	int:MYLIP
Interaction	ANAPC2 interactions	KRAS DLG5 DNAJC7 UBE2D2 ALMS1 BRCA2 RECQL4 PIBF1 PLK1	6.61e-05	234	150	9	int:ANAPC2
Interaction	COIL interactions	DHX16 PPIL4 CHD8 PAF1 SMC5 CASZ1 HOXA5 CYB5B CRNKL1 PBRM1 GCC1 CHD6 PLK1 RPL5	6.71e-05	552	150	14	int:COIL
GeneFamily	Ubiquitin conjugating enzymes E2	UBE2D2 UBE2D3 UBE2D4 UBE2Q2	8.88e-05	41	104	4	102
GeneFamily	HOXL subclass homeoboxes	CDX1 CDX2 CDX4 HOXA5	2.26e-04	52	104	4	518
GeneFamily	Ferlin family	DYSF MYOF	4.84e-04	6	104	2	828
GeneFamily	Keratins, type II	KRT72 KRT74 KRT71	4.89e-04	27	104	3	609
GeneFamily	Adenylate kinases	AK6 AK5	1.15e-03	9	104	2	356
GeneFamily	PDZ domain containing	DLG5 SHANK3 PREX2 DLG1 RIMS1	1.85e-03	152	104	5	1220
GeneFamily	Ankyrin repeat domain containing	SHANK3 ANKRD36B ASAP2 ANKRD36 ACAP2 SOWAHB	2.75e-03	242	104	6	403
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	ASAP2 ACAP2	4.21e-03	17	104	2	1291
GeneFamily	Aldehyde dehydrogenases	ALDH1A1 ALDH1A3	5.26e-03	19	104	2	398
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	NOL4 ARHGAP24 RAPGEF5 GDAP1 TBC1D2B CHRM5 SHANK3 CASZ1 ZNF248 CEMIP ANKRD36B PPARGC1A LINGO1 MTUS1 RALGPS1 RASGEF1B TENM1 CNTNAP4 NCOA7 ANKRD36 RIMS1 SSH2 UNC79 UBE2Q2	1.91e-08	1106	150	24	M39071
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	DLG5 TCF7L2 GDAP1 TBC1D2B PPIL4 CRPPA SMC5 ITPR1 NCOR2 SULF2 BRCA2 ZDHHC6 ATAD2B SVIL ZNF483 CHD6 EIF3A SSH2 ALDH1A3	5.31e-06	1009	150	19	M157
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	RAPGEF5 SHANK3 ASAP2 SULF2 LINGO1 AK5 RASGEF1B PCDH15 TNFAIP1	2.10e-08	194	150	9	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	Macroglial-Oligodendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MYO1E RAPGEF5 DYSF AK5 PIP4K2A UNC5C CNTNAP4 NCOA7 DLG1	2.73e-08	200	150	9	4dbac2f2587e87ca5a0622f50439bb5447e93c7f
ToppCell	LPS_IL1RA\|World / Treatment groups by lineage, cell group, cell type	MYO1E RAPGEF5 TM9SF3 ZNFX1 ASAP2 UBE2D3 SVIL EIF3A ALDH1A3	2.73e-08	200	150	9	a02fa5b3c4723a6eaa3c685588666c710478dd25
ToppCell	Macroglial-Oligodendrocytes-OPALIN--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MYO1E RAPGEF5 DYSF AK5 PIP4K2A UNC5C CNTNAP4 NCOA7 DLG1	2.73e-08	200	150	9	26b989e30bbbaf30904ced03f6aae3dea25c732c
ToppCell	Macroglial-Oligodendrocytes-OPALIN---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MYO1E RAPGEF5 DYSF AK5 PIP4K2A UNC5C CNTNAP4 NCOA7 DLG1	2.73e-08	200	150	9	1314664c1721e9ecb1e2c3482a039044b0fe50a9
ToppCell	Macroglial-Oligodendrocytes-OPALIN-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MYO1E RAPGEF5 DYSF AK5 PIP4K2A UNC5C CNTNAP4 NCOA7 DLG1	2.73e-08	200	150	9	8b229f095fc113aecfc94b64862a9e0fdcc363ce
ToppCell	Macroglial-Oligodendrocytes-OPALIN----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MYO1E RAPGEF5 DYSF AK5 PIP4K2A UNC5C CNTNAP4 NCOA7 DLG1	2.73e-08	200	150	9	272909f4354f3ae22e2b2f8f35970e6b0e92cfe2
ToppCell	Macroglial-Oligodendrocytes-OPALIN\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MYO1E RAPGEF5 DYSF AK5 PIP4K2A UNC5C CNTNAP4 NCOA7 DLG1	2.73e-08	200	150	9	5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DPY19L2 CASZ1 ITPR1 PPARGC1A ASAP2 UNC5C HRH2 MAP3K15	1.74e-07	179	150	8	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	COVID-19-kidney-CD-IC-B\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DLG5 DPY19L2 NEBL CFTR PPARGC1A ASAP2 ADAMTS18 NCOA7	1.98e-07	182	150	8	ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 DPY19L2 CASZ1 ITPR1 PPARGC1A ASAP2 UNC5C MAP3K15	1.98e-07	182	150	8	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 RGS22 CFTR PPARGC1A PCDH15 TENM1 CNTNAP4 UNC79	2.15e-07	184	150	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 RGS22 CFTR PPARGC1A PCDH15 TENM1 CNTNAP4 UNC79	2.15e-07	184	150	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 RGS22 CFTR PPARGC1A PCDH15 TENM1 CNTNAP4 UNC79	2.15e-07	184	150	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	SHANK3 ASAP2 SULF2 LINGO1 AK5 RASGEF1B PCDH15 TNFAIP1	2.44e-07	187	150	8	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	COVID-19-kidney-CD-IC-B\|kidney / Disease (COVID-19 only), tissue and cell type	DLG5 DPY19L2 NEBL CFTR PPARGC1A ASAP2 ADAMTS18 NCOA7	2.44e-07	187	150	8	ce05b89860573fe0356102e2998d1ef6d1968034
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SMC5 GGH ALMS1 BRCA2 RECQL4 ASPM HYLS1 ANKRD36	3.22e-07	194	150	8	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	frontal_cortex\|World / Per Region, Lineage, Cell class, Cell type, Cell subtype	TIGAR HTR1F DYSF CASZ1 SULF2 TENM1 ADAMTS18	8.59e-07	152	150	7	f9c29d4568402ca07a717dbffb3ccc7f35c5fe56
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 CASZ1 ANKRD36B GRHL1 DLG1 RIMS1 ALDH1A3	2.56e-06	179	150	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPY19L2 NEBL CFTR PPARGC1A ASAP2 ADAMTS18 NCOA7	2.65e-06	180	150	7	cfc8bfbfd3617aabbb49f9730c29b673ca157e74
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAB2 ITPR1 SULF2 LINGO1 UNC5C PCDH15 ALDH1A3	3.79e-06	190	150	7	e792e42fc49472eaf974eb0905819eb51a1da8e5
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GGH ASAP2 LINGO1 ALMS1 BRCA2 RECQL4 HYLS1	3.79e-06	190	150	7	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAB2 ITPR1 SULF2 LINGO1 UNC5C PCDH15 ALDH1A3	4.06e-06	192	150	7	550a6574a93acadb43c449094565c73ca51a0c5c
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1E RAPGEF5 DYSF SHANK3 PREX2 ASAP2 TNFAIP1	4.35e-06	194	150	7	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1E RAPGEF5 DYSF SHANK3 PREX2 ASAP2 TNFAIP1	4.35e-06	194	150	7	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAPGEF5 DYSF SHANK3 PREX2 SULF2 PIP4K2A RASSF3	4.35e-06	194	150	7	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	mild_COVID-19-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	OGFRL1 LILRB2 NAB2 NIBAN2 SULF2 RASGEF1B ALDH1A1	4.81e-06	197	150	7	5d826f4d7b7a46847c67e6bef38eb860bc808a6c
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-G\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	GDF5 NEBL RAPGEF5 ITPR1 RASGEF1B PCDH15 ALDH1A1	4.81e-06	197	150	7	a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1\|bone_marrow / Manually curated celltypes from each tissue	KIAA0930 GGH BRCA2 RECQL4 ASPM HRH2 PLK1	4.97e-06	198	150	7	5c92687b853ebb00960adbef6552f9d460bc6886
ToppCell	(11)_FOXN4+\|World / shred by cell type by condition	GGH ALMS1 BRCA2 RECQL4 ASPM HYLS1 OSCP1	4.97e-06	198	150	7	516b1acdf997dd8debc3dca066519366e507b414
ToppCell	severe-Myeloid-CD14_Monocytes_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CAPN2 NIBAN2 NCOR2 SULF2 RASGEF1B ALDH1A1 RPL5	5.14e-06	199	150	7	ce07b7c1edfc6e2136dafcf041361b66a52271d3
ToppCell	Neuronal-Excitatory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIAA0930 HTR1F RAPGEF5 ITPR1 LINGO1 HRH2 DLG1	5.31e-06	200	150	7	4409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DLG5 NEBL NIBAN2 CASZ1 MYOF MTUS1 ALDH1A1	5.31e-06	200	150	7	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RAPGEF5 DYSF MTUS1 AK5 PIP4K2A UNC5C CNTNAP4	5.31e-06	200	150	7	829978708463a7459fe1041bd90196775bc4b531
ToppCell	10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3\|bone_marrow / Manually curated celltypes from each tissue	HTR1F PCDH20 HOXA5 SVIL UNC5C HFM1	1.44e-05	155	150	6	83430a64c2cb5ad29caa3dacba76c28dd204ac40
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	CHD8 CREBL2 CYB5B HRH2 RASSF3 MAP3K15	1.67e-05	159	150	6	f34f2729a3872fbb2939e76ad35d7e25f71b8f57
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	CHD8 CREBL2 CYB5B HRH2 RASSF3 MAP3K15	1.67e-05	159	150	6	929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7
ToppCell	Control-Epithelial_alveolar-Mes-like\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UTP14A SNUPN RCC1L ALKBH8 ALDH1A1 PLK1	2.27e-05	168	150	6	3c2ce9cfaca8ceab9b29f918ab46afc69eba3330
ToppCell	Control-Epithelial_alveolar-Mes-like-AT1_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UTP14A SNUPN RCC1L ALKBH8 ALDH1A1 PLK1	2.27e-05	168	150	6	49180994311b3f4f9ec338b1d35d8edd7422e3c9
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NOL4 GDAP1 ZDBF2 KCNH2 ZNF483 UNC79	2.43e-05	170	150	6	941d637cf76918ee4b0a1833abd1a42593cb8b1a
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	KIAA0930 NIBAN2 GGH ASPM HRH2 PLK1	2.68e-05	173	150	6	783b8fa08b9d8f597f251793eae164151662f1f9
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GDF5 FASTKD1 MPZL1 CEMIP LINGO1 MAP3K15	2.86e-05	175	150	6	aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	OGFRL1 DPY19L2 BRCA2 RECQL4 ASPM PLK1	2.95e-05	176	150	6	4bba41ebf9dd187c8705a6997ed039878de62b4e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLG5 NEBL CFTR ASAP2 ADAMTS18 NCOA7	3.15e-05	178	150	6	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PPARGC1A TXNDC5 BRCA2 RECQL4 ASPM PLK1	3.25e-05	179	150	6	021d782134126c6f7dce6b6ea50cc54bdaa39987
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CFTR NIBAN2 GRHL1 MTUS1 SVIL NCOA7	3.45e-05	181	150	6	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DPY19L2 ITPR1 PPARGC1A ASAP2 UNC5C MAP3K15	3.67e-05	183	150	6	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CRPPA MTUS1 KCNH2 UNC5C HFM1 RIMS1	3.90e-05	185	150	6	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DPY19L2 CFTR CASZ1 PPARGC1A MTUS1 ADAMTS18	4.02e-05	186	150	6	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ZDBF2 OGDH KCNH2 CNTNAP4 RIMS1 UNC79	4.02e-05	186	150	6	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|bone_marrow / Manually curated celltypes from each tissue	KIAA0930 NIBAN2 DYSF GGH ASPM PLK1	4.02e-05	186	150	6	e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806
ToppCell	droplet-Marrow-BM-30m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0930 CAPN2 NIBAN2 GGH SULF2 TXNDC5	4.02e-05	186	150	6	bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883
ToppCell	COVID_non-vent-Myeloid-Dendritic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	OGFRL1 KIAA0930 MYO1E MYOF ASAP2 SULF2	4.14e-05	187	150	6	936aaca144b79a809617cbe3058bf434a4b3d46a
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	NEBL MYO1E RAPGEF5 SHANK3 PREX2 SULF2	4.14e-05	187	150	6	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	COVID_non-vent-Myeloid-Dendritic-cDC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	OGFRL1 KIAA0930 MYO1E MYOF ASAP2 SULF2	4.14e-05	187	150	6	55fe4e8b4f301876716c1af15c34d42164f2358e
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	DPY19L2 NEBL DYSF CASZ1 PPARGC1A SVIL	4.27e-05	188	150	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TTLL5 CAPN2 CRPPA ZDBF2 MTUS1 ATAD2B	4.27e-05	188	150	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TTLL5 CAPN2 CRPPA ZDBF2 MTUS1 ATAD2B	4.27e-05	188	150	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MYO1E RAPGEF5 ITPR1 MYOF SVIL RIMS1	4.27e-05	188	150	6	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TTLL5 CAPN2 CRPPA ZDBF2 MTUS1 ATAD2B	4.27e-05	188	150	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 PPARGC1A MTUS1 ASPM PCDH15 TENM1	4.27e-05	188	150	6	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYO1E CASZ1 ITPR1 MYOF ADAMTS18 UNC79	4.27e-05	188	150	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	control-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	OGFRL1 KIAA0930 IFFO1 ZNF248 UBE2D4 GCC1	4.40e-05	189	150	6	bdfd120900ba58d5e54765f7b576e1f8cc2401bf
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RAPGEF5 SHANK3 SULF2 MTUS1 AK5 PCDH15	4.40e-05	189	150	6	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	RAPGEF5 SHANK3 ITPR1 SULF2 AK5 PCDH15	4.40e-05	189	150	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 MYO1E PPARGC1A SULF2 UBE2D2 SVIL	4.40e-05	189	150	6	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 MYO1E PPARGC1A SULF2 UBE2D2 SVIL	4.40e-05	189	150	6	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	NS-critical-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GGH ASAP2 LINGO1 BRCA2 RECQL4 HYLS1	4.53e-05	190	150	6	7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR1F RAPGEF5 ITPR1 LINGO1 HRH2 DLG1	4.53e-05	190	150	6	d594da827e3c16644952b9589cc12b947ce36279
ToppCell	facs-Skin-Anagen-3m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN2 TM9SF3 MYOF KARS1 SULF2 UBE2D2	4.53e-05	190	150	6	888ded899f0513d41bf655896d59ae8ef74e0978
ToppCell	facs-Skin-Anagen-3m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN2 TM9SF3 MYOF KARS1 SULF2 UBE2D2	4.53e-05	190	150	6	3466cebab16964e94da130d0673fa32e7d90b5ed
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 CEMIP PPARGC1A MTUS1 ASPM TENM1	4.53e-05	190	150	6	e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	DPY19L2 NEBL DYSF CASZ1 PPARGC1A SVIL	4.66e-05	191	150	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RAPGEF5 DYSF SHANK3 PREX2 SULF2 NCOA7	4.66e-05	191	150	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 NEBL MYO1E GDAP1 MYOF SVIL	4.66e-05	191	150	6	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 NEBL MYO1E GDAP1 MYOF SVIL	4.66e-05	191	150	6	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOF UNC5C PCDH15 HRH2 ALDH1A1 ALDH1A3	4.80e-05	192	150	6	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RAPGEF5 PCDH20 TXNDC5 MTUS1 PIP4K2A CNTNAP4	4.94e-05	193	150	6	947200ef6c3a2e35ad7e6b4af29d92384bdf73f5
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	RAPGEF5 SHANK3 ASAP2 SULF2 AK5 PCDH15	4.94e-05	193	150	6	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GGH ASAP2 BRCA2 RECQL4 ASPM HYLS1	4.94e-05	193	150	6	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RAPGEF5 MTUS1 AK5 PIP4K2A CNTNAP4 DLG1	5.08e-05	194	150	6	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	GGH BRCA2 RECQL4 ASPM PLK1 PIWIL3	5.08e-05	194	150	6	a8ae49157ca3f9e8b3f1750a995aee012dc859b6
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TCF7L2 LILRB2 SULF2 HRH2 RASSF3 SSH2	5.08e-05	194	150	6	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GGH ASAP2 ALMS1 BRCA2 HYLS1 ANKRD36	5.08e-05	194	150	6	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TCF7L2 LILRB2 SULF2 HRH2 RASSF3 SSH2	5.08e-05	194	150	6	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAPGEF5 DYSF SHANK3 PREX2 ADAMTS18 RASSF3	5.08e-05	194	150	6	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	background-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	RAPGEF5 SHANK3 PREX2 PIP4K2A RASGEF1B NCOA7	5.23e-05	195	150	6	c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|343B / Donor, Lineage, Cell class and subclass (all cells)	OGFRL1 GGH BRCA2 RECQL4 ASPM PLK1	5.23e-05	195	150	6	47a01b8a92eebeb34ac7f70bf1ab4613a326e24f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAPGEF5 DYSF SHANK3 PREX2 SULF2 RASSF3	5.38e-05	196	150	6	023312af38f816a44b407e0daa32590d953caf99
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RAPGEF5 CHRM5 AK5 PIP4K2A UNC5C CNTNAP4	5.53e-05	197	150	6	032ccc91e604113da9bc34a6f9ddb1d45dea1892
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RAPGEF5 MTUS1 AK5 PIP4K2A UNC5C CNTNAP4	5.53e-05	197	150	6	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	droplet-Mammary_Gland-nan-18m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OGFRL1 TCF7L2 NIBAN2 SULF2 ALDH1A3 SOWAHB	5.53e-05	197	150	6	ed3a37f532741764060d297a560eeeeec279d9c4
ToppCell	COVID-19_Severe-Non-classical_Monocyte\|World / disease group, cell group and cell class	TCF7L2 NEBL LILRB2 MYOF SVIL RASGEF1B	5.53e-05	197	150	6	60fee75b12451206bb2c07b61651a73c59ec6ade
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RAPGEF5 DYSF SHANK3 PREX2 SULF2 RASSF3	5.53e-05	197	150	6	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LILRB2 SULF2 RASGEF1B HRH2 RIMS1 ALDH1A1	5.69e-05	198	150	6	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	(3)_DC_Monocyte_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	OGFRL1 GGH BRCA2 RECQL4 ASPM PLK1	5.69e-05	198	150	6	e2b89f6d7c0007ccab62495cd543fe0e5513a9a4
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RAPGEF5 DYSF SHANK3 PREX2 LINGO1 RASGEF1B	5.69e-05	198	150	6	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	MYO1E PREX2 MYOF SVIL ADAMTS18 NCOA7	5.69e-05	198	150	6	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	Monocytes\|World / Immune cells in Kidney/Urine in Lupus Nephritis	OGFRL1 KIAA0930 TCF7L2 LILRB2 ADORA3 MYOF	5.69e-05	198	150	6	8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61
ToppCell	critical-Epithelial-FOXN4+\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SMC5 GGH ASAP2 BRCA2 HYLS1 ANKRD36	5.69e-05	198	150	6	6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A	TCF7L2 FASTKD1 CHD8 ZNF248 HOXA5 ALMS1 ASPM PLK1 ACAP2	3.30e-06	181	150	9	1791_DN
Drug	Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; HL60; HT_HG-U133A	NEBL LILRB2 TTLL5 MPZL1 ADORA3 MYOF MTUS1 PIP4K2A TNFAIP1	6.31e-06	196	150	9	2576_DN
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A	ARHGAP24 IFFO1 TTLL5 CFTR NAB2 UTP14A AK5 RALGPS1 ZER1	6.84e-06	198	150	9	3730_DN
Disease	urate measurement	NOL4 TCF7L2 NEBL RAPGEF5 SNX17 AK6 DYSF KCNK9 CEMIP CYB5B ASAP2 AK5 NCOA7 HFM1 UBE2Q2	4.67e-05	895	148	15	EFO_0004531
Disease	Vertigo	TIGAR CAPN2 ARMC9 CHRM5 SVIL RIMS1	7.47e-05	139	148	6	HP_0002321
Disease	diastolic blood pressure, systolic blood pressure	TIGAR ARMC9 KCNK9 CASZ1 CEMIP CYB5B PPARGC1A ALMS1 SVIL PIP4K2A CHD6 PIBF1	1.50e-04	670	148	12	EFO_0006335, EFO_0006336
Disease	Joubert syndrome 1	ARMC9 HYLS1 PIBF1	1.54e-04	21	148	3	C4551568
Disease	Ciliopathies	CFTR CCDC39 NPHP3 PCDH15 HYLS1	2.38e-04	110	148	5	C4277690
Disease	Woolly hair, congenital	KRT74 KRT71	2.47e-04	5	148	2	C0345427
Disease	Klatskin's tumor (is_implicated_in)	KRAS PREX2	2.47e-04	5	148	2	DOID:4927 (is_implicated_in)
Disease	retinal vasculature measurement	DHX16 TCF7L2 TTLL5 NIBAN2 DYSF COG8 ITPR1 MYOF LINGO1 RASGEF1B	2.95e-04	517	148	10	EFO_0010554
Disease	Polydactyly	GDF5 LMBR1 NPHP3 ALMS1 HYLS1	3.17e-04	117	148	5	C0152427
Disease	electrocardiography	ARHGAP24 ZNFX1 ARMC9 CASZ1 CEMIP PPARGC1A KCNH2 SVIL ADAMTS18 NCOA7	3.59e-04	530	148	10	EFO_0004327
Disease	Hypotrichosis	KRT74 KRT71	3.70e-04	6	148	2	C0020678
Disease	Pituitary Gland Adenoma	NEBL PCDH15	3.70e-04	6	148	2	EFO_1000478
Disease	Familial aplasia of the vermis	ARMC9 HYLS1 PIBF1	4.55e-04	30	148	3	C0431399
Disease	creatinine measurement	TCF7L2 SNX17 ARMC9 SNUPN CASZ1 BRWD3 CEMIP PPARGC1A UBE2D3 ALMS1 SVIL NCOA7 DLG1 UBE2Q2	5.03e-04	995	148	14	EFO_0004518
Disease	CHARGE syndrome (implicated_via_orthology)	CHD8 CHD6	5.16e-04	7	148	2	DOID:0050834 (implicated_via_orthology)
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF MYOF	5.16e-04	7	148	2	DOID:11724 (implicated_via_orthology)
Disease	Wooly hair	KRT74 KRT71	5.16e-04	7	148	2	C0343073
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	TCF7L2 CYB5B SULF2 AK5 RALGPS1 DLG1 SSH2 UNC79	5.23e-04	364	148	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Schizophrenia	TCF7L2 HTR1F MPZL1 CHRM5 SHANK3 PPARGC1A PBRM1 TXNDC5 KCNH2 PIP4K2A UNC5C DLG1 ALDH1A1	5.27e-04	883	148	13	C0036341
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	KRAS TCF7L2 TTLL5 DYSF RASGEF1B	5.32e-04	131	148	5	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	KRAS TCF7L2 TTLL5 DYSF RASGEF1B	5.32e-04	131	148	5	C4552091
Disease	Juvenile arthritis	KRAS TCF7L2 TTLL5 DYSF RASGEF1B	5.32e-04	131	148	5	C3495559
Disease	Juvenile psoriatic arthritis	KRAS TCF7L2 TTLL5 DYSF RASGEF1B	5.32e-04	131	148	5	C3714758
Disease	Squamous cell carcinoma of lung	KRAS MAP3K15 PLK1	5.51e-04	32	148	3	C0149782
Disease	Juvenile-Onset Still Disease	KRAS TCF7L2 TTLL5 DYSF RASGEF1B	6.10e-04	135	148	5	C0087031
Disease	Malignant neoplasm of urinary bladder	KRAS GGH BRCA2 RALGPS1 CHD6	7.42e-04	141	148	5	C0005684
Disease	obesity (implicated_via_orthology)	TCF7L2 CAPN2 ITPR1 PPARGC1A ALMS1 ALDH1A1	7.79e-04	215	148	6	DOID:9970 (implicated_via_orthology)
Disease	age at menarche	NOL4 TCF7L2 KCNK9 PCDH20 CYB5B SULF2 LINGO1 ALMS1 ZNF483 UNC79	8.64e-04	594	148	10	EFO_0004703
Disease	Pancreatic carcinoma, familial	KRAS BRCA2	8.79e-04	9	148	2	C2931038
Disease	Autosomal Recessive Polycystic Kidney Disease	CFTR NPHP3	8.79e-04	9	148	2	C0085548
Disease	response to anticonvulsant	TDRD15 NEBL PREX2 SOWAHB	8.98e-04	85	148	4	GO_0036277
Disease	autism spectrum disorder (implicated_via_orthology)	CHD8 SHANK3 CNTNAP4 CHD6 RIMS1	1.04e-03	152	148	5	DOID:0060041 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of breast	KRAS PBRM1 BRCA2	1.15e-03	41	148	3	C0496956
Disease	Breast adenocarcinoma	KRAS PBRM1 BRCA2	1.15e-03	41	148	3	C0858252
Disease	Carcinoma, Transitional Cell	GGH HRH2 CHD6	1.15e-03	41	148	3	C0007138
Disease	albuminuria	TCF7L2 RAPGEF5 SNX17 AK5	1.31e-03	94	148	4	EFO_0004285
Disease	Macrocephaly	CHD8 BRWD3	1.33e-03	11	148	2	C0221355
Disease	waist circumference	TCF7L2 NEBL CFTR CAPN2 GDAP1 CYB5B RASGEF1B PIBF1	1.50e-03	429	148	8	EFO_0004342
Disease	eye disease	TCF7L2 RASGEF1B TMCO1	1.50e-03	45	148	3	EFO_0003966
Disease	distal myopathy (implicated_via_orthology)	MYH3 DYSF	1.60e-03	12	148	2	DOID:11720 (implicated_via_orthology)
Disease	response to hydrochlorothiazide, fasting blood glucose measurement	KRAS ARMC9 PCDH15	1.60e-03	46	148	3	EFO_0004465, EFO_0005202
Disease	ovary epithelial cancer (is_marker_for)	ASPM PLK1	1.88e-03	13	148	2	DOID:2152 (is_marker_for)
Disease	Benign tumor of pancreas	KRAS BRCA2	1.88e-03	13	148	2	C0347284
Disease	Intellectual Disability	SNX3 CHD8 ARMC9 SHANK3 BRWD3 KARS1 ALKBH8 TMCO1	1.94e-03	447	148	8	C3714756
Disease	sitting height ratio	TCF7L2 CRPPA ATAD2B	2.16e-03	51	148	3	EFO_0007118
Disease	balding measurement	DLG5 TCF7L2 KRT74 RGS22 CRPPA CASZ1 ITPR1 NCOR2 SULF2 KRT71 ADAMTS18	2.23e-03	792	148	11	EFO_0007825
Disease	pancreatic cancer (is_implicated_in)	KRAS TCF7L2 CFTR BRCA2	2.48e-03	112	148	4	DOID:1793 (is_implicated_in)
Disease	N-acetylmethionine measurement	ITPR1 ALMS1	2.51e-03	15	148	2	EFO_0021427
Disease	Huntington's disease (biomarker_via_orthology)	ITPR1 PPARGC1A	2.86e-03	16	148	2	DOID:12858 (biomarker_via_orthology)
Disease	dysmenorrheic pain measurement	KRAS GDAP1	2.86e-03	16	148	2	EFO_0007889
Disease	cleft lip	LILRB2 CCDC168 KCNK9 NCOR2 SVIL PIP4K2A	3.18e-03	284	148	6	EFO_0003959
Disease	uridine diphosphate galactose measurement, uridine diphosphate glucose measurement	SVIL ADAMTS18	3.23e-03	17	148	2	EFO_0010543, EFO_0010544
Disease	microglial activation measurement	ARHGAP24 ARMC9 PCDH20	3.27e-03	59	148	3	EFO_0010940
Disease	neuroimaging measurement, brain volume measurement	GDF5 TCF7L2 CYB5B PPARGC1A PBRM1 NCOA7	3.29e-03	286	148	6	EFO_0004346, EFO_0006930
Disease	body fat percentage	TCF7L2 CYB5B SULF2 AK5 RALGPS1 DLG1 SSH2 UNC79	3.32e-03	488	148	8	EFO_0007800
Disease	Meckel syndrome type 1	NPHP3 HYLS1	3.63e-03	18	148	2	C3714506
Disease	Pancreatic carcinoma	KRAS BRCA2	4.04e-03	19	148	2	C0235974
Disease	diet measurement, HOMA-B	CREBL2 CYB5B	4.04e-03	19	148	2	EFO_0004469, EFO_0008111
Disease	emphysema pattern measurement	SVIL SOWAHB	4.04e-03	19	148	2	EFO_0005850
Disease	attention deficit hyperactivity disorder, schizophrenia	TCF7L2 NAB2 UBE2D3	4.12e-03	64	148	3	EFO_0003888, MONDO_0005090
Disease	Disorder of eye	KCNV2 NPHP3 ALMS1 PCDH15 RIMS1	4.40e-03	212	148	5	C0015397
Disease	heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer	TCF7L2 GRHL1	4.47e-03	20	148	2	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992
Disease	calcium measurement	KRAS TBC1D2B CRPPA CHD8 ITPR1 GGH GRHL1 ASAP2 HFM1	4.54e-03	628	148	9	EFO_0004838
Disease	social deprivation, COVID-19	ARHGAP24 PCDH20	4.93e-03	21	148	2	EFO_0009696, MONDO_0100096
Disease	BREAST CANCER	KRAS BRCA2	4.93e-03	21	148	2	114480

Protein segments in the cluster

Peptide	Gene	Start	Entry
TRTKDKYRVVYTDHQ	CDX1	151	P47902
VKTRTKDKYRVVYTD	CDX2	181	Q99626
KDKYRVVYTDHQRLE	CDX2	186	Q99626
RTKEKYRVVYTDHQR	CDX4	171	O14627
AVKVYRLITRNSYER	CHD8	1251	Q9HCK8
KLTRYRSEKVTISYA	AMMECR1L	271	Q6DCA0
TELKLTRKAAYVRYF	CFTR	291	P13569
RVRRIHVKRYSTYDD	TNFAIP1	291	Q13829
RYRAITDAVEYARKR	HTR1F	121	P30939
VDRYLRVKLTVRYKR	ADORA3	106	P0DMS8
RYRTTEESKRAYVTL	ALKBH8	86	Q96BT7
SKRARFSKYEEYIRK	CASZ1	231	Q86V15
KRSLYVRALFDYDKT	DLG1	581	Q12959
EKRKSEYKSYRLRAQ	ALMS1	4136	Q8TCU4
VYSEFVRRSVEYAKK	ALDH1A3	326	P47895
AVRIYQQKRLYKRSE	CNTNAP4	1261	Q9C0A0
DRVTVLYRSKAIRYT	COQ6	161	Q9Y2Z9
YVRAVRKSKIYSVNL	BRWD3	956	Q6RI45
YDEFVRRSVERAKKY	ALDH1A1	316	P00352
LLLTYYDANKRDRKE	ANKRD36	51	A6QL64
LTYYDANKRDRKERT	ANKRD36B	41	Q8N2N9
RQEKEAYIRAKYVER	ACAP2	496	Q15057
KYKRRVRDLAREYRA	DHX16	271	O60231
RFDTYRSKKESERLV	CEMIP	206	Q8WUJ3
KKYATYRASAIIIQR	ASPM	2061	Q8IZT6
SRSKVVDRIYSLYKL	ASPM	3391	Q8IZT6
TYRERLYRVYKEVKN	ATP5PB	181	P24539
VLYKRTAEEKIQRYR	ADAMTS18	201	Q8TE60
VDEKYRYKQRQIREL	CCDC39	736	Q9UFE4
RSRKDKTRGYEYVLE	RCC1L	146	Q96I51
FYTLVREIRQYRLKK	KRAS	156	P01116
LKRRYTAYRQKLEEA	RASSF3	216	Q86WH2
EDNYKRTREYIRSLK	RALGPS1	181	Q5JS13
YKRDLYAAESIIKER	CRPPA	266	A4D126
RVLERVLKKYDYDSS	NIBAN2	471	Q96TA1
YQTDLYERERSKKRD	PPIL4	461	Q8WUA2
VLYERLETRGYNEKK	AK6	101	Q9Y3D8
IRIKGKYNISSEDYR	KCNK9	46	Q9NPC2
AYKESYKDRRRRAHT	MLX	121	Q9UH92
RRRAKESKVREYYEK	NCOR2	321	Q9Y618
QLDREEKEKYRYTVR	PCDH20	596	Q8N6Y1
EYFVYTIRDRRERRK	OGFRL1	281	Q5TC84
YEAVKNYTDKRGRRL	PBRM1	666	Q86U86
DKTVYEYLFSQRRKR	GDF5	366	P43026
YNYRVVKEILIRLSK	ITPR1	1181	Q14643
TKTIAKRLEAYYRAS	AK5	511	Q9Y6K8
RLKEFYTREYEKLRD	MTUS1	1006	Q9ULD2
RKYSIIYGRFDSKRR	NAB2	296	Q15742
YFIITRYKRKSDEQE	LMBR1	36	Q8WVP7
IYRHRKDYDKSQLVE	ATAD2B	1431	Q9ULI0
ARKDYITAKYIERRY	ASAP2	521	O43150
ERRSVTYLKRYNKIQ	ARMC9	221	Q7Z3E5
RLVRVARKLDRYSEY	KCNH2	531	Q12809
SIRYEALKKVYDNRV	KIAA0930	206	Q6ICG6
LETYYERVLKRKTFN	GDAP1	276	Q8TB36
KRARTAYTRYQTLEL	HOXA5	196	P20719
LRVFKARIYTNRYET	FBXO39	396	Q8N4B4
TLQEIYRKYRKLIES	FBXO39	416	Q8N4B4
TYYRIFKVARDQAKR	HRH2	201	P25021
ELAAYVRRLERKYSS	COG8	176	Q96MW5
DYDALRKRYSEKVAI	DLG5	316	Q8TDM6
GSLEAQEYRLYREKK	LILRB2	51	Q8N423
RDYSFKRLYRLKVLE	LINGO1	231	Q96FE5
LRARTKIVYSTYSRK	DPY19L2	666	Q6NUT2
ILAVLYRRKNSKRDY	MPZL1	186	O95297
YSERKKTRNLEAYVE	RASGEF1B	246	Q0VAM2
YKEQVRKIGEEARRY	RIMS1	91	Q86UR5
LYNVLAKVKRERDEY	IFFO1	241	Q0D2I5
YAYSVRDSKLRDILK	HFM1	566	A2PYH4
KREEYRREYEKRESE	PPARGC1A	646	Q9UBK2
GKVYYDLTRERKARD	OGDH	906	Q02218
LRKRLNYEDKTRYFV	PCDH15	216	Q96QU1
VYYNELETRVRLSKR	PAF1	321	Q8N7H5
KLEDTVRYEKRYGNR	ARHGAP24	136	Q8N264
RVRVIYKYALDRISK	CRNKL1	431	Q9BZJ0
YQARLKDVVRAYKSL	GCC1	31	Q96CN9
NRGKTDRVARYFEYK	HYLS1	206	Q96M11
DYYKVPRERRSSTAK	GRHL1	66	Q9NZI5
YEKRREFEKLTQVYR	DOCK11	1726	Q5JSL3
LKYRYDTEIDRSRRS	BRCA2	2656	P51587
DLRRSDYAKVAKIFY	GGH	101	Q92820
RQRKEERRITYYREK	EIF3A	796	Q14152
AVKVYRLITRNSYER	CHD6	901	Q8TD26
SARECRARKKLRYQY	CREBL2	36	O60519
RARKKLRYQYLEELV	CREBL2	41	O60519
YYRLEEVAKRNSLKE	CYB5B	26	O43169
AKSIAKFLRNVRYRY	FASTKD1	231	Q53R41
VKLDDTYIKAYLRRA	DNAJC7	321	Q99615
RRLYEKKIFEYETQR	EMD	31	P50402
TRREKAEYVTEITRY	CCDC168	4101	Q8NDH2
RDRKKRVYDYESERL	CCDC168	6971	Q8NDH2
KYQKIYREIDVDRSG	CAPN2	606	P17655
DDKRRYDSIKRYLCT	PIWIL3	586	Q7Z3Z3
LRVEKYLRRRKYSLF	DYSF	581	O75923
TLVSVYCTRKKYRER	MEP1B	671	Q16820
VYRKYDLKGSTVARE	PIP4K2A	206	P48426
KSSRDYRRAAKYDVI	KRBA2	151	Q6ZNG9
YVTEDFTTYINRKRK	OTUD5	261	Q96G74
VYYKETLLNDIRKAR	MAP3K15	241	Q6ZN16
VKYDSRLRERKYGVV	TIGAR	81	Q9NQ88
VYRTDKYKRLKAEVE	TMCO1	81	Q9UM00
ARYKAERRRQLAEKY	SVIL	106	O95425
KDKETRYRQRYLDLI	KARS1	221	Q15046
RYSKDRRFYRAVITE	TDRD15	541	B5MCY1
LKEIRRTELKRYYSI	NCOA7	76	Q8NI08
YERLRKEYEIFRVSK	NPHP3	91	Q7Z494
ITYRDRNQRKAKSIY	RGS22	891	Q8NE09
EETRALYREYRTLKR	RECQL4	36	O94761
SKLKAYEYTTIRRER	KCNV2	501	Q8TDN2
EYHYKSKVRVLRIDA	SOCS4	421	Q8WXH5
KSLEASGRIYVYRKD	RAPGEF5	306	Q92565
YQVKFRRRREGKTDY	RPL5	16	P46777
GKTDYYARKRLVIQD	RPL5	26	P46777
RRVLYKYTKQARLSE	TENM1	1966	Q9UKZ4
LRKYERRVKELTYQS	MYH3	1841	P11055
YKSKYSSLEQSERRR	SNUPN	31	O95149
LYSKKALRTVYERLA	OSCP1	71	Q8WVF1
DGTKYVVLKRRYRDL	SOWAHB	66	A6NEL2
YQERARKRIRTYLKS	NOL4	451	O94818
ILYCRIYRETEKRTK	CHRM5	211	P08912
SLRSQEYKIVLRKSY	SNX17	191	Q15036
KRVRSVRYKVIEDYS	ZDHHC6	311	Q9H6R6
IYKTDREKYNRIARE	UBE2D2	126	P62837
RSYNYKKSRKVFRQT	ZFP28	811	Q8NHY6
KELRDIYRSQSYKTG	UBE2Q2	211	Q8WVN8
SRKKYDVRRVYLGEA	ZNF653	51	Q96CK0
DRLSSYYKFKLTREV	ZER1	256	Q7Z7L7
DRAYDYVKERRTVTK	SSH2	416	Q76I76
RYKRRVYAQNLIDDK	SHANK3	91	Q9BYB0
LSREEQAKYYELARK	TCF7L2	391	Q9NQB0
YRYLIESVRQRDSKI	PIBF1	626	Q8WXW3
IYKTDRDKYNRISRE	UBE2D3	126	P61077
DIIRKYISKYSVFLR	ZDBF2	2221	Q9HCK1
VIRDKDYHLRTYKSV	PREX2	496	Q70Z35
RALQSYYEAKARREK	UTP14A	231	Q9BVJ6
KLKESTVRRRYSDFE	SNX3	61	O60493
RRKILSYERQYRTSA	ZNFX1	946	Q9P2E3
RTLRKDYARYSKEEE	TM9SF3	246	Q9HD45
LRVYLRKKSRRYNES	ZNF483	321	Q8TF39
QYKGKRDLESLREYV	TXNDC5	276	Q8NBS9
TYKADREKYNRLARE	UBE2D4	126	Q9Y2X8
YDKYGIRIRVKFRSS	SMC5	966	Q8IY18
RKAYVRIAYLRKTFE	UNC5C	156	O95185
KYLRYFTRTILDARK	TBC1D2B	886	Q9UPU7
KSYLEILAEVRDYKR	SNRNP48	206	Q6IEG0
ILAEVRDYKRRRQSY	SNRNP48	211	Q6IEG0
KYKASYVRSRSIRSV	SULF2	526	Q8IWU5
QGAYTRKILREYKVS	ZNF248	316	Q8NDW4
ERYHLSYKIVRTDSR	TTLL5	61	Q6EMB2
YELTRKDRLYKNIIR	TTLL5	126	Q6EMB2
YRAFTKERDKFYLSR	UNC79	2246	Q9P2D8
TYIDEKRDFRTYRLS	PLK1	551	P53350
LRNVRDVVEDYKKRY	KRT71	206	Q3SY84
YKKRYEVEINRRTAA	KRT72	211	Q14CN4
YKKRYEVEINRRTTA	KRT74	226	Q7RTS7
RERKYDGYARVIQKS	MYO1E	691	Q12965
DLLVVEKYQRRRKYS	MYOF	561	Q9NZM1
EKYQRRRKYSLSAVF	MYOF	566	Q9NZM1
LRAKRTSEIYSQRKY	NEBL	546	O76041